Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* age \>18 years~* the presence of 2-10 facial AK lesions~Exclusion Criteria:~* lactating or pregnant women~* patients with porphyria~* a known allergy to any of the constituents of the MAL cream and lidocaine~* patients with systemic disease~* history of malignant melanoma~* tendency for melasma development or keloid formation~* any AK treatment of the area in the previous 4 weeks~* any conditions associated with a risk of poor protocol compliance~* patients on immunosuppressive treatment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 87 Years
- Healthy Volunteers: t

Study Arms:
- 2h-AFL-PDT (Type: EXPERIMENTAL): All 440 AK lesions of the 93 patients were randomly assigned to treatment with MAL-PDT (3h-MAL-PDT) or AFL-PDT with 2 hours (2h-AFL-PDT) and 3 hours (3h-AFL-PDT) of incubation time, using restricted randomization, with a computer-generated program.
- 3hr-AFL-PDT (Type: ACTIVE_COMPARATOR): All 440 AK lesions of the 93 patients were randomly assigned to treatment with MAL-PDT (3h-MAL-PDT) or AFL-PDT with 2 hours (2h-AFL-PDT) and 3 hours (3h-AFL-PDT) of incubation time, using restricted randomization, with a computer-generated program.
- 3hr-MAL-PDT (Type: ACTIVE_COMPARATOR): All 440 AK lesions of the 93 patients were randomly assigned to treatment with MAL-PDT (3h-MAL-PDT) or AFL-PDT with 2 hours (2h-AFL-PDT) and 3 hours (3h-AFL-PDT) of incubation time, using restricted randomization, with a computer-generated program.

Based on this trial design, predict the completion outcome and termination type (if applicable).